1. Home
  2. PROK vs NC Comparison

PROK vs NC Comparison

Compare PROK & NC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • NC
  • Stock Information
  • Founded
  • PROK 2015
  • NC 1913
  • Country
  • PROK United States
  • NC United States
  • Employees
  • PROK N/A
  • NC N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • NC Coal Mining
  • Sector
  • PROK Health Care
  • NC Energy
  • Exchange
  • PROK Nasdaq
  • NC Nasdaq
  • Market Cap
  • PROK 206.0M
  • NC 233.7M
  • IPO Year
  • PROK N/A
  • NC N/A
  • Fundamental
  • Price
  • PROK $1.50
  • NC $32.86
  • Analyst Decision
  • PROK Buy
  • NC
  • Analyst Count
  • PROK 5
  • NC 0
  • Target Price
  • PROK $4.50
  • NC N/A
  • AVG Volume (30 Days)
  • PROK 344.0K
  • NC 7.5K
  • Earning Date
  • PROK 03-21-2025
  • NC 03-05-2025
  • Dividend Yield
  • PROK N/A
  • NC 2.77%
  • EPS Growth
  • PROK N/A
  • NC N/A
  • EPS
  • PROK N/A
  • NC N/A
  • Revenue
  • PROK N/A
  • NC $224,047,000.00
  • Revenue This Year
  • PROK N/A
  • NC N/A
  • Revenue Next Year
  • PROK N/A
  • NC N/A
  • P/E Ratio
  • PROK N/A
  • NC N/A
  • Revenue Growth
  • PROK N/A
  • NC 1.12
  • 52 Week Low
  • PROK $1.34
  • NC $25.19
  • 52 Week High
  • PROK $4.44
  • NC $34.74
  • Technical
  • Relative Strength Index (RSI)
  • PROK 41.47
  • NC 65.95
  • Support Level
  • PROK $1.50
  • NC $31.35
  • Resistance Level
  • PROK $1.67
  • NC $31.99
  • Average True Range (ATR)
  • PROK 0.10
  • NC 0.70
  • MACD
  • PROK -0.00
  • NC 0.08
  • Stochastic Oscillator
  • PROK 10.71
  • NC 74.04

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.

Share on Social Networks: